Drug Availability

HPS Pharmacies wish to give notice that all suppliers are experiencing a supply interruption for tranexamic acid tablets as follows:

Cyklokapron Tablets
Tranexamic acid 500mg
ARTG 14463

APO-Tranexamic Acid Tablets
Tranexamic acid 500mg
ARTG 272732, 272727

Normal supplies are expected to resume in late June 2021. An internationally registered brand of tranexamic acid 500mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.

The Section 19A alternative is presented in blister packs of 60 tablets, while the Australian registered brands contain 100 tablets. The international brand also does not have storage conditions printed on the carton. It is recommended that the product is stored in line with the recommendations of the Australian registered product, i.e. below 25°C.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates